Masami Ijiri

465 total citations
18 papers, 362 citations indexed

About

Masami Ijiri is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masami Ijiri has authored 18 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masami Ijiri's work include Inflammatory Bowel Disease (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Acute Myeloid Leukemia Research (2 papers). Masami Ijiri is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Acute Myeloid Leukemia Research (2 papers). Masami Ijiri collaborates with scholars based in Japan and United States. Masami Ijiri's co-authors include Shin Kashima, Toshikatsu Okumura, Mikihiro Fujiya, Aki Sakatani, Kentaro Moriichi, Hiroaki Konishi, Junpei Sasajima, Takuma Goto, Kazuyuki Tanaka and Yusuke Mizukami and has published in prestigious journals such as Molecules, BMC Cancer and Surgical Endoscopy.

In The Last Decade

Masami Ijiri

16 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masami Ijiri Japan 7 237 177 98 57 41 18 362
Harsh Patel United States 9 157 0.7× 70 0.4× 112 1.1× 44 0.8× 20 0.5× 21 345
Aki Sakatani Japan 13 335 1.4× 203 1.1× 177 1.8× 113 2.0× 74 1.8× 36 617
Nisha R. Pawar United States 6 117 0.5× 45 0.3× 72 0.7× 33 0.6× 9 0.2× 8 267
Seyed Esmaeil Ahmadi Iran 10 206 0.9× 44 0.2× 74 0.8× 11 0.2× 36 0.9× 16 364
Vanessa Sandim Brazil 10 167 0.7× 62 0.4× 48 0.5× 23 0.4× 5 0.1× 18 289
Ioannis A. Avramis United States 9 175 0.7× 45 0.3× 79 0.8× 31 0.5× 17 0.4× 14 493
Yaling Dou China 10 139 0.6× 100 0.6× 41 0.4× 17 0.3× 14 0.3× 35 277
Huini Wu China 10 128 0.5× 78 0.4× 119 1.2× 42 0.7× 7 0.2× 20 309
Min Lan China 13 115 0.5× 83 0.5× 70 0.7× 108 1.9× 13 0.3× 20 329

Countries citing papers authored by Masami Ijiri

Since Specialization
Citations

This map shows the geographic impact of Masami Ijiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Ijiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Ijiri more than expected).

Fields of papers citing papers by Masami Ijiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Ijiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Ijiri. The network helps show where Masami Ijiri may publish in the future.

Co-authorship network of co-authors of Masami Ijiri

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Ijiri. A scholar is included among the top collaborators of Masami Ijiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Ijiri. Masami Ijiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tanabe, Hiroki, Y. Koshizuka, Kazuyuki Tanaka, et al.. (2024). High-resolution genetic analysis of whole APC gene deletions: a report of two cases and patient characteristics. Human Genome Variation. 11(1). 46–46. 1 indexed citations
2.
Konishi, Hiroaki, et al.. (2024). Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model. Pediatric Hematology and Oncology. 41(5). 367–375.
3.
Tanabe, Hiroki, Masami Ijiri, Kenji Takahashi, et al.. (2024). Genomic insights into familial adenomatous polyposis: unraveling a rare case with whole APC gene deletion and intellectual disability. Human Genome Variation. 11(1). 13–13. 2 indexed citations
4.
Konishi, Hiroaki, et al.. (2023). Cmpd10357 to treat B-cell acute lymphoblastic leukemia. Experimental Hematology. 119-120. 8–13.e1.
5.
Konishi, Hiroaki, Connie P.M. Duong, Masami Ijiri, et al.. (2022). A distinct subpopulation of leukemia initiating cells in acute precursor B lymphoblastic leukemia: quiescent phenotype and unique transcriptomic profile. Frontiers in Oncology. 12. 972323–972323. 3 indexed citations
6.
Ijiri, Masami, Regina Gandour‐Edwards, Joyce Lee, et al.. (2021). Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib. Frontiers in Oncology. 11. 648097–648097. 5 indexed citations
7.
Ijiri, Masami, Takahiro Sasaki, Mikihiro Fujiya, et al.. (2020). The efficacy of the submucosal injection of lidocaine during endoscopic submucosal dissection for colorectal neoplasms: a multicenter randomized controlled study. Surgical Endoscopy. 35(9). 5225–5230. 3 indexed citations
8.
Fujiya, Mikihiro, Hiroaki Konishi, Hiroki Tanaka, et al.. (2020). Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. International Journal of Oncology. 57(3). 721–732. 50 indexed citations
9.
Takahashi, Keitaro, Mikihiro Fujiya, Nobuhiro Ueno, et al.. (2019). White coat status is a predictive marker for post-esophageal endoscopic submucosal dissection stricture: a retrospective study. Esophagus. 16(3). 258–263. 5 indexed citations
11.
Ando, Katsuyoshi, Mikihiro Fujiya, Yoshiki Nomura, et al.. (2018). The Incidence and Risk Factors of Venous Thromboembolism in Patients with Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study. Digestion. 100(4). 229–237. 16 indexed citations
12.
Goto, Takuma, Mikihiro Fujiya, Hiroaki Konishi, et al.. (2018). An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer. 18(1). 116–116. 195 indexed citations
13.
Tanaka, Kazuyuki, Mikihiro Fujiya, Masami Ijiri, et al.. (2018). A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy. Journal of Gastrointestinal Cancer. 50(3). 617–620. 3 indexed citations
14.
Fujiya, Mikihiro, Shin Kashima, Masami Ijiri, et al.. (2018). Takayasu’s arteritis associated with eosinophilic gastroenteritis, possibly via the overactivation of Th17. Gut Pathogens. 10(1). 22–22. 2 indexed citations
15.
Ando, Katsuyoshi, Mikihiro Fujiya, Yoshiki Nomura, et al.. (2018). The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study. Intestinal Research. 16(3). 416–416. 23 indexed citations
16.
Ijiri, Masami, Mikihiro Fujiya, Hiroaki Konishi, et al.. (2017). Ferrichrome identified from Lactobacillus casei ATCC334 induces apoptosis through its iron-binding site in gastric cancer cells. Tumor Biology. 39(6). 3726132731–3726132731. 26 indexed citations
17.
Ijiri, Masami, et al.. (2016). Syphilis infection throughout the whole gastrointestinal tract. Endoscopy. 48(S 01). E338–E339. 6 indexed citations
18.
Moriichi, Kentaro, Mikihiro Fujiya, Masami Ijiri, et al.. (2015). Quantification of autofluorescence imaging can accurately and objectively assess the severity of ulcerative colitis. International Journal of Colorectal Disease. 30(12). 1639–1643. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026